Grant: Operating Grant
McMaster University
$83,445.00
Colchicine for Prevention of Peri-Operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery (COP-AF) Pilot Trial
FY 2012-13
Summary
Statement of health problem
Patients undergoing surgery are at risk for many complications. Atrial fibrillation (fast chaotic heart beats) is one of the most common serious complications after thoracic surgery. As many as 1 in 4 patients will develop atrial fibrillation after thoracic surgery. Patients who develop atrial fibrillation after surgery often develop worse outcomes such as: death, stroke, longer hospital stay. Strokes after surgery are usualy devastating leaving most patient incapacitated or severely limited (require assistance to perform daily activities of living). Preventing atrial fibrillation resulted in less strokes and shorter hospital stay. Atrial fibrillation occurs when there is excessive inflammation in the body (such as after surgery); regulating the inflammation in the body after surgery resulted in less atrial fibrillation. Colchicine is a safe and effective anti-inflammatory drug and we anticipate that it will prevent almost half (45%) of atrial fibrillation after surgery.
Objective of project
Test if colchicine is effective in preventing atrial fibrillation after surgery. The pilot trial (50 patients) represent an initial foundation for a larger trial with hundreds of patients.
How will you undertake your work?
The study is in two major hospitals in Canada; St. Joseph hospital (Hamilton, ON) and University of Manitoba Health Sciences Centre, Winnipeg. The Population Health Research Instituite in Hamilton will be the coordinating site. Patients will receive colchicine or placebo pill for 10 days after the surgery and will be monitored to see if they develop atrial fibrillation.
What is unique/innovative about your project?
The solution we are proposing will represent a safe/cheap medication to prevent a major complication. Effective prevention of atrial fibrillation will result in less strokes and shorter hospital stay.
Department
Program
Operating Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
281597
Name
Devereaux Philip J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
Colchicine for Prevention of Peri-Operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery (COP-AF) Pilot Trial
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$83,445
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Atrial Fibrillation; Colchicine; Randomized Controlled Trial; Thoracic Surgery
Abstract
Statement of health problem
Patients undergoing surgery are at risk for many complications. Atrial fibrillation (fast chaotic heart beats) is one of the most common serious complications after thoracic surgery. As many as 1 in 4 patients will develop atrial fibrillation after thoracic surgery. Patients who develop atrial fibrillation after surgery often develop worse outcomes such as: death, stroke, longer hospital stay. Strokes after surgery are usualy devastating leaving most patient incapacitated or severely limited (require assistance to perform daily activities of living). Preventing atrial fibrillation resulted in less strokes and shorter hospital stay. Atrial fibrillation occurs when there is excessive inflammation in the body (such as after surgery); regulating the inflammation in the body after surgery resulted in less atrial fibrillation. Colchicine is a safe and effective anti-inflammatory drug and we anticipate that it will prevent almost half (45%) of atrial fibrillation after surgery.
Objective of project
Test if colchicine is effective in preventing atrial fibrillation after surgery. The pilot trial (50 patients) represent an initial foundation for a larger trial with hundreds of patients.
How will you undertake your work?
The study is in two major hospitals in Canada; St. Joseph hospital (Hamilton, ON) and University of Manitoba Health Sciences Centre, Winnipeg. The Population Health Research Instituite in Hamilton will be the coordinating site. Patients will receive colchicine or placebo pill for 10 days after the surgery and will be monitored to see if they develop atrial fibrillation.
What is unique/innovative about your project?
The solution we are proposing will represent a safe/cheap medication to prevent a major complication. Effective prevention of atrial fibrillation will result in less strokes and shorter hospital stay.
Competitiondate
201303
Approvedterm2
1 yr 6 mths
Pinamesdelim
Devereaux, Philip J; Srinathan, Sadeesh K
Approvedterm
1 an 6 mois
Cihrcontribution2
~ $83,445~ $0~